Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT02226692
Other study ID # UQTR-2011-PFAC
Secondary ID
Status Completed
Phase N/A
First received August 12, 2014
Last updated May 26, 2015
Start date October 2011
Est. completion date September 2014

Study information

Verified date May 2015
Source Université du Québec à Trois-Rivières
Contact n/a
Is FDA regulated No
Health authority Canada: Ethics Review Committee
Study type Observational

Clinical Trial Summary

The aim of the present study is to quantify the relative contribution of variables obtained during a physical fitness evaluation and a short screening questionnaire in determining the short-term and long term risk of persistent disabling low back pain in patients with chronic low back pain. It has been hypothesized that patients with higher physical fitness will present a lower risk of persistent disabling low back pain and so, a lower score on the questionnaire.


Recruitment information / eligibility

Status Completed
Enrollment 53
Est. completion date September 2014
Est. primary completion date July 2014
Accepts healthy volunteers No
Gender Both
Age group 18 Years to 60 Years
Eligibility Inclusion Criteria:

- adults between 18 and 60 years old

- nonspecific low back pain : pain located between the twelfth rib and the inferior gluteal fold for which no specific source of pain could be identified

- chronic low back pain : pain present for 12 weeks or more, and included both constant and recurrent patterns of pain

- able to read and understand French

Exclusion Criteria:

- History of surgery or major trauma to the spine

- Current use of medication known to impair physical effort and pain perception

- Lumbar scoliosis of more than 20°

- Collagenosis, severe osteoporosis

- Neuromuscular disease

- Malignant tumor

- Non-controlled hypertension

- Infection

- Radiculopathy

- Progressive neurologic defect

- Myelopathy

- Lumbar disc hernia

- Pregnancy

- Active lower body injury and/or severe and disabling pain limiting the capacity to undergo the evaluation.

Study Design

Observational Model: Cohort, Time Perspective: Prospective


Locations

Country Name City State
Canada Université du Québec à Trois-Rivières Trois-Rivières Quebec

Sponsors (3)

Lead Sponsor Collaborator
Université du Québec à Trois-Rivières Fonds de la Recherche en Santé du Québec, Institut de Recherche Robert-Sauvé en Santé et en Sécurité du Travail

Country where clinical trial is conducted

Canada, 

Outcome

Type Measure Description Time frame Safety issue
Primary Disability level Oswestry disability index 2 months No
Primary Disability level Oswestry disability index 4 months No
Primary Disability level Oswestry disability index 6 months No
Primary Disability level Oswestry disability index 12 months No
Secondary Pain intensity in the past 2 months 101 points numerical rating scale 2 months No
Secondary Fear of movement level Tampa scale for kinesiophobia 2 months No
Secondary Patient's global impression of change from baseline Patient's global impression of change scale 6 months No
Secondary Patient's global impression of change from 6 months Patient's global impression of change scale 12 months No
Secondary Pain intensity in the past 2 months 101 points numerical rating scale 4 months No
Secondary Pain intensity in the past 2 months 101 points numerical rating scale 6 months No
Secondary Pain intensity in the past 6 months 101 points numerical rating scale 12 months No
Secondary Pain intensity in the past week 101 points numerical rating scale 12 months No
Secondary Fear of movement level Tampa scale for kinesiophobia 4 months No
Secondary Fear of movement level Tampa scale for kinesiophobia 6 months No
Secondary Fear of movement level Tampa scale for kinesiophobia 12 months No
See also
  Status Clinical Trial Phase
Completed NCT03243084 - Transcranial Alternating Current Stimulation in Back Pain- Pilot Sudy N/A
Suspended NCT04735185 - Stem Cells vs. Steroids for Discogenic Back Pain N/A
Completed NCT03162952 - RAND Center of Excellence for the Study of Appropriateness of Care in CAM
Completed NCT03240146 - Pulsed Shortwave Therapy Treatment for Chronic Musculoskeletal Low Back Pain N/A
Completed NCT05282589 - Lumbopelvic Manipulation Effects on Fatigue in Chronic Low Back Pain Patients N/A
Completed NCT03637998 - Physical Activity on Neurophysiologic Gene Expression Profiles of Chronic Low Back Pain N/A
Recruiting NCT02289170 - Clinical Study to Evaluate the Safety and Efficacy of Heating and Cooling Combination Therapeutic Device(OCH-S100) N/A
Active, not recruiting NCT01944163 - The IMPACT of a Referral Model for Axial Spondyloarthritis in Young Patients With Chronic Low Back Pain N/A
Completed NCT02231554 - Feldenkrais vs Back School for Treating Chronic Low Back Pain: a Randomized Controlled Trial N/A
Recruiting NCT02063503 - Identification of Prognostic Indicators for Rehabilitation in Chronic Nonspecific Low Back Pain Patients N/A
Terminated NCT01620775 - MR(Magnetic Resonance) Imaging of Neurotransmitters in Chronic Pain N/A
Completed NCT01704677 - Lumbar Disc Prosthesis Versus Multidisciplinary Rehabilitation; 8-year Follow-up N/A
Completed NCT01177280 - Prevalence of Potential Cytochrome P450 Pharmacokinetic Incident Drug-Drug Interactions Among Chronic Low Back Pain Patients Taking Opioid Analgesics and Associated Economic Outcomes N/A
Completed NCT01490905 - A Double Blind Placebo Study to Determine the Effectiveness of Theramine on the Management of Chronic Back Pain Phase 4
Completed NCT01177241 - Cytochrome P450 Pharmacokinetic DDIs Among Patients With Chronic Low Back Pain Taking Opioids N/A
Completed NCT01177254 - Exposure to Potential Cytochrome P450 Pharmacokinetic Drug-Drug Interactions Among Osteoarthritis Patients: Incremental Risk of Multiple Prescriptions N/A
Completed NCT00984815 - Safety Study of HZT-501 in Patients Who Require Long-Term Daily Non-steroidal Anti-inflammatory Drug Treatment Phase 3
Completed NCT00767806 - A Study for Patient With Chronic Low Back Pain Phase 3
Completed NCT00761150 - Study to Evaluate the Safety and Efficacy of ABT-712 in Subjects With Moderate to Severe Chronic Low Back Pain (CLBP) Phase 3
Completed NCT00763321 - Study to Evaluate the Safety and Efficacy of ABT-712 in Subjects With Moderate to Severe Chronic Low Back Pain (CLBP) Phase 3